| Vical,
Inc. develops biopharmaceutical products based on our patented
naked DNA gene transfer technologies for the prevention and
treatment of life-threatening diseases. We currently focus our
development on innovative cancer therapies designed to induce
an immune response against cancer cells without causing serious
side effects. |
|
 |
|
|
|
|
